pharmaceuticals

The Most Common Drug Conviction for ICE Detainees? Rx Drug Possession

Since the very beginning of his path to and through the White House, Donald Trump has slandered undocumented people migrating…

December 2, 2019

Canadian Pharmacist Punished for Grassroots Naloxone Distribution

An Ontario regulatory organization for pharmacists is cracking down on a grassroots harm reductionist for his naloxone distribution efforts—even though…

November 4, 2019

Will the FDA Repeat Its “Abuse-Deterrent” Oxy Mistake With Stimulants?

OxyContin got a makeover in 2010. That year, the Food and Drug Administration approved a new version of the opioid,…

September 20, 2019

Is the Purdue Settlement a Win for Harm Reduction?

The battle to hold corporations accountable for their involvement in fueling chaotic opioid use and overdose deaths in vulnerable communities…

September 16, 2019

Pain Patients Like Me Are Rising Up Against Discrimination and Suffering

If it were up to me, it’s unlikely I would be sitting down to write about my life with chronic…

May 13, 2019

Gilead Relinquishes Its PrEP Patent—But Did It Mislead Investors?

On May 8, pharmaceutical company Gilead quietly announced that it will relinquish its exclusive patent on Truvada for HIV pre-exposure…

May 8, 2019

Bernie Sanders Backs #BreakThePatent Fight for Universal PrEP Access

The fight for universal access to PrEP medication for HIV prevention was picked up by Vermont Senator and presidential hopeful…

April 29, 2019

New “Generic” Naloxone: Expect More Big-Pharma Sleight of Hand

It's been less than two weeks since the US Department of Justice joined a string of lawsuits against Indivior—the maker…

April 24, 2019

DEA’s “Innovative” Strategy in New Orleans Encourages Ever-Harsher Prosecutions

On April 16, the Drug Enforcement Administration (DEA) launched its latest punishment-driven, treatment-inflected response to the opioid-involved overdose crisis in…

April 17, 2019

Indivior Case: Don’t Throw Out the Buprenorphine With the Bathwater

In the lucrative but hit-and-miss opioid use disorder treatment field, buprenorphine is one medication that has demonstrated outstanding efficacy.  It’s…

April 16, 2019